News Conference News ESC 2016 NOACs as Effective as Warfarin for Reducing Stroke, but Apixaban and Dabigatran May Carry Lower Bleeding Risk: Registry Michael O'Riordan August 28, 2016
News Conference News ESC 2016 New ESC A-fib Guidelines Call for Integrated Care for All Patients Todd Neale August 27, 2016
News Daily News Drug Company Payments to Physicians May Be Influencing Prescribing Todd Neale August 23, 2016
News Daily News Warfarin Control Over Time Is Shaky Even in Those Who Are Initially Stable Todd Neale August 10, 2016
News Daily News A la Larga el Control de la Warfarina es Complicado Incluso en Pacientes Inicialmente Inestables Todd Neale August 10, 2016
News Daily News ARISTOTLE Analysis: Don’t Shy Away From Standard Apixaban Dose in Certain High-Risk Patients Todd Neale July 29, 2016
News Daily News Study Provides More Evidence That Having A-fib Ups Risk of Developing Dementia L.A. McKeown July 19, 2016
News Daily News FDA: No More Chances for Embattled Coagulation Monitoring System Todd Neale July 13, 2016
News Daily News FDA: No Más Oportunidades para el Acosado Sistema para Monitorizar la Coagulación Todd Neale July 13, 2016
News Daily News ROCKET AF Investigators Respond to New Questions About Point-of-Care Warfarin Monitoring Device Todd Neale July 08, 2016
News Daily News Chinese Patients With A-fib Are at Especially High Risk of Stopping Warfarin Todd Neale July 08, 2016
News Daily News New A-fib Performance and Quality Measures Emphasize Shared Decision-Making, Inpatient and Outpatient Care Michael O'Riordan June 29, 2016
News Daily News Sigue Abusándose de la Aspirina como Protección Única frente a los ACV en Pacientes con FA Todd Neale June 27, 2016
News Daily News Aspirin as Standalone Stroke Protection Still Overused for Patients With A-fib Todd Neale June 27, 2016
News Daily News Black Individuals Have Less A-fib, but When They Do, the Consequences Are More Dire Michael O'Riordan June 24, 2016
News Conference News TVT 2016 Teenage TAVR: Should Practice Forge on While Guidelines Grow Up? Michael O'Riordan June 20, 2016